巴瑞克替尼相关类|Baricitinib related-毕得医药

搜索购物车会员中心

巴瑞克替尼是一种治疗类风湿性关节炎（RA）的药物，是由英格尔和伊莉莉开发的。它作为JAK激酶的抑制剂，阻断JAK1和JAK2亚型。该药在欧洲获得批准。

默认常备现货
纯度
- 请选择
- 99+%
- 99%
- 98+%
- 98%
- 97+%
- 97%
- 96+%
- 96%
- 95+%
- 95%
- 93%
- 90+%
- 90%
规格
- 请选择
- 1mg
- 2mg
- 5mg
- 10mg
- 25mg
- 50mg
- 100mg
- 250mg
- 1g
- 5g
- 10g
- 25g
- 100g
- 500g
- 1000g
- 1kg

清空选项

4-(1-(1-Ethoxyethyl)-1H-pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine 4-(1-(1-Ethoxyethyl)-1H-pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine 品牌：毕得: BD6264961187595-88-597%; 登录 250mg 常备现货

tert-Butyl 3-(cyanomethylene)azetidine-1-carboxylate tert-Butyl 3-(cyanomethylene)azetidine-1-carboxylate 品牌：毕得: BD2172341153949-11-198%; 登录 100g 常备现货

1-(1-Ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole 1-(1-Ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole 品牌：毕得: BD1962531029716-44-695%; 登录 250mg 常备现货

4-Chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine 4-Chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine 品牌：毕得: BD196746941685-26-398%; 登录 5g 常备现货

1-Benzhydrylazetidin-3-ol 1-Benzhydrylazetidin-3-ol 品牌：毕得: BD1902718621-17-598%; 登录 500g 常备现货

Epichlorohydrin Epichlorohydrin 品牌：毕得: BD40228106-89-899%; 登录 500mL

1-Benzhydrylazetidin-3-ol hydrochloride 1-Benzhydrylazetidin-3-ol hydrochloride 品牌：毕得: BD2307090604-02-796%; 登录 100g

1